A Search Service for Abbreviation / Long Form

■ 略語/展開語 : RT/radiation treatment

[関連PubMed/MEDLINE情報]
合計出現文献数: 127
[表示件数]
100 件 (発表年降順)
100 件 (発表年昇順)
>> 全件
[1ページの表示件数]
ページ移動
/ ページ
略語:   RT  (>> 共起略語)
展開形:   radiation treatment
 略語バリエーション
 展開形バリエーション
 ペア(略語/展開形)バリエーション
No. 発表年 題目 共起略語
2022 Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. CFRT, GI, SBRT
2022 Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation. BF, BV, DCE-CT, NELM
2022 Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. ---
2022 Mapping the prevalence and use of questionnaires to detect the neglected sexual side effects after prostate cancer treatment: a scoping review. NSSE, PCa, RP
2022 Sociodemographic and Clinical Factors Associated with Radiation Treatment Nonadherence and Survival among Rural and Nonrural Cancer Patients. RUCC
2021 3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity. TIME
2021 A Machine Learning Model Approach to Risk-Stratify Patients With Gastrointestinal Cancer for Hospitalization and Mortality Outcomes. AUC, GI
2021 A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choices. SDM
2021 Advanced Imaging Techniques for Radiotherapy Planning of Gliomas. FLAIR, MRI, PET
10  2021 Automated health chats for symptom management of head and neck cancer patients undergoing radiation therapy. CRO, PRO
11  2021 Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ. AI, DCIS, TAM
12  2021 GAN for synthesizing CT from T2-weighted MRI data towards MR-guided radiation treatment. cGAN, MAE, MRI, MSE, PCC, PSNR, sCT
13  2021 Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy. CCRT, PMBC
14  2021 Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC. CTV, EBUS-TBNA, LN, NSCLC
15  2021 Impact of the COVID-19 Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution. ---
16  2021 Mesenchymal Stem Cell-Conditioned Medium Protects Hippocampal Neurons From Radiation Damage by Suppressing Oxidative Stress and Apoptosis. CCK-8, MDA, MSC-CM, ROS, SOD
17  2021 MMP-9 reinforces radiation-induced delayed invasion and metastasis of neuroblastoma cells through second-signaling positive feedback with NFkappaB via both ERK and IKK activation. NB, PFC
18  2021 Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization. NPC, OER, PDX
19  2021 Patient-Reported Pain in Patients with Breast Cancer Who Receive Radiotherapy. ESAS, QoL
20  2021 Ultra-low-dose radiation treatment for early-stage ocular adnexal MALT lymphoma. CR, MALT
21  2020 A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study. CBC, CI, RR, WECARE
22  2020 Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?: A National Cancer Database analysis. ART, EC, FIGO, NCDB, OS, TI
23  2020 Evaluation of variables associated with outcomes in 41 dogs with incompletely excised high-grade soft tissue sarcomas treated with definitive-intent radiation therapy with or without chemotherapy. HGSTSs, HR, OST, TTP
24  2020 Height, weight, and cardiovascular effects of stimulants on children with brain tumors. BMI, BP
25  2020 Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients. SLNB
26  2020 Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience. OS, PFA, PFB, PFE, PFS
27  2020 Manganese Porphyrin and Radiotherapy Improves Local Tumor Response and Overall Survival in Orthotopic Murine Mammary Carcinoma Models. MnPs
28  2020 Music therapy and radiation oncology: State of art and future directions. ---
29  2020 Quality improvement in paediatric radiation oncology through peer review. ANZ
30  2020 Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study. AS, CSS, MAS, OS, SEER
31  2019 Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response. RCC
32  2019 Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells. HIF-1alpha, NSCLC, VEGFR2
33  2019 Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC. HNC, SP
34  2019 How do patient characteristics and anatomical features correlate to accuracy of organ dose reconstruction for Wilms' tumor radiation treatment plans when using a surrogate patient's CT scan? ---
35  2019 Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review. NHL, PS
36  2019 Predictive factors for persistent and late radiation complications in breast cancer survivors. ARLEC, RLEs
37  2019 Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound. HGGs, HT, MRgFUS
38  2019 Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies. ---
39  2019 Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy. RTCT
40  2019 Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy. AJCC, CRT, Ed, FDG-PET, HPV OPSCC, OS, UICC
41  2018 An Acrylic Immobilization Bite Block for Use During Radiation Therapy: Description of a New Technique. ---
42  2018 Analysis of Magnetic Resonance Image Signal Fluctuations Acquired During MR-Guided Radiotherapy. MLCs, MRgRT, MRI, PCA, QA
43  2018 Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/beta-catenin modulation in colorectal cancer cells exposed to gamma-radiation. CRC, DHA
44  2018 Dose-volume metrics and their relation to memory performance in pediatric brain tumor patients: A preliminary study. ---
45  2018 Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. ---
46  2018 Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis. BM, EGFR, iPFS, mOS, NSCLC, SRS, TKIs, WBRT
47  2018 Hypofractionated radiation treatment in the management of breast cancer. CF-WBI, HF-WBI
48  2018 Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer? GTV, non-ADC, NSCLC, VRR
49  2018 NECESSITY OF MULTIMODAL TREATMENT OF ACROMEGALY AND OUTCOMES. IGF-1
50  2018 Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data. GMs
51  2018 Salvage therapy outcomes for atypical meningioma. LFFR
52  2018 Sigmoid colon perforation after postoperative hypofractionated intensity-modulated radiation therapy in a cervical cancer patient. ---
53  2018 SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. ADT, LAPC, RP
54  2018 Utilization of a hybrid finite-element based registration method to quantify heterogeneous tumor response for adaptive treatment for lung cancer patients. DIR, DVFs, FEM, GTVs, NSCLC, PET, TLG
55  2017 A Potential Role for Green Tea as a Radiation Sensitizer for Prostate Cancer. PCa
56  2017 Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer. ---
57  2017 Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET. AD, BF, IMRT, PF
58  2017 Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV. HT, RF, TEF, TM
59  2017 General health status of long-term cervical cancer survivors after radiotherapy. LCCS, QoL
60  2017 Onsite versus offsite radiation treatment of malignant spinal cord compression: lessons from a safety net health system. MSCC
61  2017 Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy. CFRT, ChRT, NSCLC, PCA, SBRT
62  2017 Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer. NSCLC, OR, OS
63  2017 Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor. ALDH, AT/RT, BCL2, DSF
64  2017 Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis. EOR, GTR, WHO
65  2017 The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line. RFHT, TEF
66  2017 The role of radiotherapy in the management of high-grade meningiomas. OS
67  2017 Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. DSBs, TTFields
68  2017 What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis. CT, EC, HR, OS
69  2016 An update on the multimodality of localized rectal cancer. LARC, LR, OS, RC, TME
70  2016 Evaluating organ preservation outcome as treatment endpoint for T1aN0 glottic cancer. LFS, LFS-DSS, SCC, TLM
71  2016 Impact of a Novel Bioabsorbable Implant on Radiation Treatment Planning for Breast Cancer. BCS
72  2016 Improving the Quality of Radiation Treatment for Patients in Ontario: Increasing Peer Review Activities on a Jurisdictional Level Using a Change Management Approach. ---
73  2016 Omega-3 prevents myelin degeneration in rat foetuses exposed to radiation. CNS and PNS, FA
74  2016 Patient's quality of life after high-dose radiation therapy for thoracic carcinomas : Changes over time and influence on clinical outcome. QoL
75  2016 Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. BMDCs, IFP, STP
76  2016 Solitary brain metastasis from prostate cancer: a case report. ---
77  2016 Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis. EOR, SEER
78  2016 Technical Note: Development and performance of a software tool for quality assurance of online replanning with a conventional Linac or MR-Linac. MU, QA, TPS
79  2015 Chronic radiation proctitis: tricks to prevent and treat. CRP
80  2015 Factors associated with radiation therapy incompletion for patients with early-stage breast cancer. BCS, cGy, CI, OR
81  2015 Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment. AQUA, DSS, IHC, LI, nFD, OSCC, TMA
82  2014 FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer. CT, FDG, GTV, NSCLC
83  2014 Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma. DSS, OS, RFS
84  2014 Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. DSS, LVSI, OS
85  2014 Utility of an Australasian registry for children undergoing radiation treatment. ---
86  2013 18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model. ---
87  2013 An overview of craniospinal axis fields and field matching. CA, CSA
88  2013 Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas. CD, FSRT, IMRT, RION, SRS, TLN
89  2013 Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. CR/GR, FAO, GSC, MES, PN, ROS, TMZ
90  2013 The benefits of photodynamic therapy on vertebral bone are maintained and enhanced by combination treatment with bisphosphonates and radiation therapy. BP, PDT
91  2012 Setup variations in radiotherapy of anal cancer: advantages of target volume reduction using image-guided radiation treatment. AP, IGRT, MVCT, PTV, SI
92  2012 Symptom clusters in patients with bone metastases--a reanalysis comparing different statistical methods. EFA, HCA, PCA
93  2012 The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. DSS, IRB, LVSI, OS, RFS
94  2011 Adjuvant radiation treatment after prostatectomy. Where do we stand? ART, SRT
95  2011 Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. MCT
96  2011 The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas. FRT, GKRS
97  2011 What QLQ-C15-PAL Symptoms Matter Most for Overall Quality of Life in Patients With Advanced Cancer? QoL
98  2011 [Long-term control of sacral metastasis from rectal cancer with S-1 + radiation treatment (RT) and mFOLFOX6 combination therapy--a case report]. ---
99  2010 Inhibiting PI3K/Akt pathway increases DNA damage of cervical carcinoma HeLa cells by drug radiosensitization. Dq, MTT, SER
100  2010 Protective effects of melatonin and octreotide against radiation-induced intestinal injury. ---